Search

everythinglearnresearchcommunity

for

Search:↓

Hair growth and shedding are linked and can be disrupted, causing a delay known as the hair eclipse phenomenon, which is common in certain hair conditions and could lead to new treatments.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Acitretin improved monilethrix symptoms temporarily, but they returned after stopping treatment.

Clascoterone cream was approved in the USA for treating acne in people aged 12 and older.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Cacumen Platycladi extract can safely and effectively reduce hair loss and increase hair density.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

A child with ectodermal dysplasia-syndactyly syndrome has a new mutation in the NECTIN4 gene.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

The plant extract helped increase hair growth in men without severe side effects.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Using microneedles before applying eflornithine cream can make it more effective at stopping hair growth.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Tiny lipid particles carrying 17-α-estradiol gather in hair follicles, which may help target alopecia treatment.

Necl2 affects skin cell behavior and slows wound healing.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Equisetum debile extract may help with hair loss by inhibiting enzymes and reducing inflammation.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

A man had a rare skin reaction from a hair loss medication, which improved after stopping the drug.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Erlotinib may cause scarring hair loss.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

ECS may help treat hair loss by promoting hair cell growth.

Aminopterin effectively improves skin conditions but has toxic side effects that need careful monitoring.